Matthew Baggott

Company: Tactogen Inc

Job title: Co-Founder & Chief Executive Officer

Seminars:

Innovating Entactogens, a Novel Class of Psychoactive Agents, to Revolutionize Applications of MDMA & Related Molecules 4:10 pm

Mapping the chemical space around MDMA to identify optimized entactogens with the off-target effects minimized Removing patient-excluding side effects, such as hypertension and anxiety, to enhance the accessibility of MDMA treatment Mitigating the variable pharmacodynamics of MDMA to precisely refine patient dosing and selectionRead more

day: Conference Day One